New FDA-proved obesity drugs, ‘Belviq’ and ‘Contrave,’ entered the domestic market

In the domestic obesity treatment market which has been depressed after expulsion of sibutramine, a series of new obesity drugs have attracted attention of the market.

While Ildong Pharmaceutical has regularized marketing of ‘Belviq,’ a FDA-proved obesity treatment of Arena Pharmaceuticals from the U.S., since March, Kwang Dong Pharmaceutical signed a domestic sales contract for another FDA-pr...